Multiple methods within a single trial [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2019-03-13 18:44 (675 d 18:06 ago) – Posting: # 20027
Views: 3,194

Dear Ohlbe,

» I would reverse the question: why would you use two different methods, or two different technologies, within a single BE trial, with the risk of increasing variability? We're not talking of 2 different trials here (where one can be done at one CRO and the other at another CRO, with a different method).

Please think about very big clinical trials which required a multi-centers ( e.g for Anti-cancer drugs), you deal here with different CRO's which could have different technologies.

Best regards,


Complete thread:

 Admin contact
21,303 posts in 4,441 threads, 1,487 registered users;
online 7 (0 registered, 7 guests [including 5 identified bots]).
Forum time: Sunday 12:51 CET (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz